Bobloblawslawblog@lemmy.world to Medicine@lemmy.worldEnglish · 2 years agoAxi-cel CAR-T cell therapy in second line for aggressive B-cell lymphoma confers an overall survival benefit over standard of care salvage chemotherapy.plus-squarewww.nejm.orgexternal-linkmessage-square0fedilinkarrow-up11arrow-down10
arrow-up11arrow-down1external-linkAxi-cel CAR-T cell therapy in second line for aggressive B-cell lymphoma confers an overall survival benefit over standard of care salvage chemotherapy.plus-squarewww.nejm.orgBobloblawslawblog@lemmy.world to Medicine@lemmy.worldEnglish · 2 years agomessage-square0fedilink
